| Product ID |
Product Name |
CAS# |
Purity |
| Y1258969 |
SMARCA-BD ligand 1 for Protac dihydrochloride |
2369053-68-7 |
98% |
| Y1245794 |
PROTAC IRAK4 degrader-1 |
2360533-90-8 |
99% |
| Y3292859 |
SJFa |
2254609-27-1 |
99% |
| Y3295891 |
Sincalide ammonium |
70706-98-8 |
99% |
| Y1254570 |
N-piperidine Ibrutinib hydrochloride |
2231747-18-3 |
95% |
| Y3317902 |
DAMGO (TFA) |
950492-85-0 |
99% |
| Y3259982 |
Bax activator-1 |
1638526-94-9 |
98% |
| Y3309090 |
Lanraplenib succinate |
1800047-00-0 |
98.58% |
| Y3106328 |
Pam3CSK4 TFA (112208-00-1 free base) |
112208-01-2 |
98% |
| Y3296336 |
Eupalinolide O |
2170228-67-6 |
99% |
| Y3269545 |
Bcl-2/Bcl-xl inhibitor 1 |
2180923-05-9 |
99% |
| Y3312959 |
Uncarinic acid E |
277751-61-8 |
98.0% |
| Y1342751 |
J22352 |
2252395-44-9 |
99% |
| Y3313476 |
4H-1-Benzopyran-4-one,2,3-dihydro-5-hydroxy-3-[(4-hydroxyphenyl)methyl]-7-methoxy- |
108001-32-7 |
98% |
| Y3259971 |
MI-1061 |
1410737-34-6 |
99% |
| Y3288829 |
Wedeliatrilolactone A |
156993-29-2 |
98.0% |
| Y3315931 |
3,4,5'-Trimethoxy-3',4'-methylenedioxy-7,9':7',9-diepoxylignan |
873867-94-8 |
95% |
| Y3254099 |
Minimolide F |
1367351-41-4 |
98.56% |
| Y3317635 |
10β-Hydroxycadina-4,11(13)-dien-12,8β-olide |
35001-23-1 |
90.0% |
| Y3318372 |
2alpha-Hydroxy-8beta-(2-methylbutyryloxy)costunolide |
128286-87-3 |
95% |
| Y3310741 |
Biatractylolide |
182426-37-5 |
98% |
| Y3314635 |
Filicenol B |
145103-37-3 |
97.5% |
| Y3297729 |
8-Epixanthatin |
30890-35-8 |
95% |
| Y3316109 |
4,2'-Dihydroxy-4'-methoxychalcone |
63529-06-6 |
98% |
| Y3106311 |
Ciwujiatone |
218901-26-9 |
95% |
| Y3264666 |
MS4077 |
2230077-10-6 |
99% |
| Y3307736 |
Astin A |
151201-75-1 |
98% |
| Y3315417 |
Voafinidine |
180059-77-2 |
97.5% |
| Y3236871 |
Echitoveniline |
72855-79-9 |
98.0% |
| Y3308097 |
Bidenoside C |
700877-55-0 |
98% |
| Y3242908 |
12alpha-Methoxygrandiflorenic acid |
135383-94-7 |
98.0% |
| Y3245185 |
Diversoside |
55062-36-7 |
95% |
| Y3251558 |
1-O-Acetyl-6-O-isobutyrylbritannilactone |
1613152-34-3 |
97.5% |
| Y3314563 |
Cryptanoside A |
98570-81-1 |
95% |
| Y3305181 |
Hythiemoside B |
853267-90-0 |
95% |
| Y3313660 |
13-O-Ethylpiptocarphol |
202522-40-5 |
95.0% |
| Y3313541 |
ent-17-Hydroxykaura-9(11),15-dien-19-oic acid |
1588516-88-4 |
97.5% |
| Y3311054 |
Senkyunolide G |
94530-85-5 |
95% |
| Y3292668 |
Rauvovertine A |
2055073-75-9 |
Powder |
| Y3245380 |
3'-O-Methylmurraol |
1891097-17-8 |
98.5% |
| Y3310804 |
Ginsenoside MC |
175484-06-7 |
95% |
| Y1254571 |
Y06036 |
1832671-96-1 |
99% |
| Y3311938 |
11-Anhydro-16-oxoalisol A |
156338-93-1 |
95% |
| Y1254574 |
BA-53038B |
2306195-65-1 |
98% |
| Y1250259 |
QM385 |
2093421-02-2 |
99% |
| Y1344450 |
Tubulin inhibitor 1 |
2237054-53-2 |
99% |
| Y1254681 |
Glutaminase-IN-1 |
2247127-79-1 |
98% |
| Y3106506 |
Dibritannilactone B |
1829580-18-8 |
97.5% |
| Y3305688 |
1-(2,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)propan-1-one |
221696-69-1 |
98% |
| Y1254600 |
MARK4 inhibitor 1 |
2271081-58-2 |
98% |
| Y1250260 |
DDX3-IN-1 |
1919828-83-3 |
99% |
| Y3286287 |
threo-6'-Hydroxyustusolate C |
1175543-07-3 |
97.5% |
| Y3293088 |
Cyclo(Ile-Ala) |
90821-99-1 |
99% |
| Y3315611 |
Scillascillone |
2023822-40-2 |
98.0% |
| Y3297875 |
Celosin I |
1807732-38-2 |
99% |
| Y1259014 |
4,4,5,5-tetramethyl-2-[1,1':3',1''-terphenyl]-2-yl-1,3,2-Dioxaborolane |
1872426-73-7 |
98% |
| Y3306444 |
6-Hydroxykaempferol 3-beta-rutinoside |
205527-00-0 |
98% |
| Y1258925 |
SEC inhibitor KL-1 |
900308-84-1 |
99% |
| Y1254596 |
Cysteinylglycine TFA |
1100364-95-1 |
98% |
| Y1254709 |
BI-1935 |
940954-41-6 |
98% |
| Y3311805 |
Celosin J |
1623405-29-7 |
98% |
| Y1343225 |
NBDHEX |
787634-60-0 |
98% |
| Y1258926 |
Nampt-IN-5 |
2380013-17-0 |
99% |
| Y3109791 |
Gypenoside LXXV |
110261-98-8 |
98.0% |
| Y3305897 |
Secologanic acid |
60077-46-5 |
98% |
| Y3288017 |
Shancigusin I |
1435488-35-9 |
98% |
| Y1344207 |
CDDO-2P-Im |
1883650-96-1 |
98% |
| Y1263319 |
mGluR2 antagonist 1 |
1432728-49-8 |
99% |
| Y1259015 |
Salfaprodil |
916214-57-8 |
98% |
| Y1258891 |
TBAP-001 |
1777832-90-2 |
99% |
| Y1344187 |
SIRT7 inhibitor 97491 |
1807758-81-1 |
98% |
| Y1259016 |
TAK-615 |
1664335-55-0 |
99% |
| Y1263321 |
MDR-652 |
1933528-96-1 |
98% |
| Y1259017 |
p38a inhibitor 2 |
1095003-80-7 |
98% |
| Y1344569 |
Benpyrine |
2550398-89-3 |
99% |
| Y1259018 |
Aß42-IN-2 |
1914989-80-2 |
98% |
| Y3317280 |
Yadanzioside G |
95258-17-6 |
98.0% |
| Y3315320 |
Isoasiaticoside |
948827-09-6 |
95% |
| Y3310625 |
Emodin-1-O-beta-gentiobioside |
849789-95-3 |
95% |
| Y3296048 |
Cyanosafracin B |
96996-50-8 |
95% |
| Y1338321 |
methyl 4-chloro-1H-indazole-7-carboxylate |
952479-72-0 |
97% |
| Y3316554 |
[12]-Dehydrogingerdione |
99742-05-9 |
95% |
| Y3106325 |
Delbonine |
95066-33-4 |
97.0% |
| Y3309243 |
Gymnoside IX |
898827-00-4 |
98% |
| Y3310593 |
3-O-a-L-rhamnopyranosyl (12)[ß-D-glucopyranosyl (14)]-a-L-arabinopyranosyl-27-hydroxyoleanolic acid 28-O-a-L-rhamnopyranosyl (14)-ß-D-glucopyranosyl (16)-ß-D-glucopyranoside |
938160-21-5 |
98% |
| Y3106380 |
Acuminatanol |
948884-38-6 |
98.0% |
| Y3288439 |
L-lysine compound with (((2S,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl dihydrogen phosphate and ethanol (1:1:1) |
914361-45-8 |
99% |
| Y3315682 |
Gymnoside VII |
899430-07-0 |
98% |
| Y3307264 |
(R)-2-Methyl-4-(8-methyl-7-(1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline |
923272-18-8 |
98% |
| Y3311294 |
6'-O-ß-D-Glucopyranosyl phlorigidoside C |
927691-83-6 |
98% |
| Y1254599 |
FASN-IN-1 |
1808260-84-5 |
99% |
| Y1259019 |
MCB-3681 |
790704-42-6 |
98% |
| Y1258980 |
5-Iodo-indirubin-3'-monoxime |
331467-03-9 |
99% |
| Y1259053 |
HO-1-IN-1 hydrochloride |
1092851-70-1 |
99% |
| Y1263357 |
MCL-1/BCL-2-IN-3 |
2163793-55-1 |
99% |
| Y1342445 |
AGX51 |
330834-54-3 |
99% |
| Y3309113 |
N-(Phenylmethyl)heptadecanamide;N-benzyl-heptadecanamide |
883715-19-3 |
98% |
| Y3311181 |
(Z)-Leukadherin-1 |
2055362-72-4 |
98.0% |
| Y3312852 |
Phoyunnanin E |
886747-60-0 |
95% |
| Y1343328 |
Prexasertib dimesylate |
1234015-58-7 |
98% |